Target Audience

This accredited continuing education activity is designed for clinical providers and nurses from MFM, OB, L&D, mother/baby units, outpatient clinics, and QI leaders.

Educational Objectives

At the conclusion of this activity, the participants should be better able to:

• Describe the importance of timely postpartum follow-up for patients with a hypertensive disorder of pregnancy.
• Identify best practices for scheduling postpartum follow-up for patients with a hypertensive disorder of pregnancy.
• Identify strategies to ensure patients receive postpartum blood pressure monitoring.

Accredited Continuing Education

In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.

Method of Participation

In order to receive continuing education credits, you must complete these steps prior to the activity expiration date:

• View the entire presentation.
• Complete the post-test with a score of 2 out of 3 or better.
• Complete the online evaluation.
• Save and print your certificate. Retain for future documentation.

Disclosure Declaration

As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.

All faculty, planners, and others in a position to control continuing education content participating in a UNMC accredited activity are required to disclose all financial relationships with ineligible companies. As defined by the Standards for Integrity and Independence in Accredited Continuing Education, ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating relevant financial relationships in accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.

This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.

All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC.

Disclosures